Virtual Reality Reduces Pre-Procedural Anxiety in TEER Pa-tients, But Timing Seems Crucial
Overview
- Phase
- Not Applicable
- Status
- Completed
- Sponsor
- Abby Geerlings
- Enrollment
- 75
- Locations
- 1
- Primary Endpoint
- Change in Pre-procedural anxiety
Overview
Brief Summary
This study aims to evaluate the effect of adding virtual reality (VR) education to standard pre-procedural information on anxiety levels in patients scheduled for MitraClip or TricuspidClip procedures. Participants will receive either standard pre-procedural information or standard information supplemented with a VR experience that explains the procedure and hospital environment. The main outcomes will include changes in patient-reported anxiety before and after the procedure. The goal of this study is to determine whether the use of VR can improve patient understanding, reduce procedural anxiety, and enhance overall well-being
Study Design
- Study Type
- Interventional
- Allocation
- Randomized
- Intervention Model
- Parallel
- Primary Purpose
- Supportive Care
- Masking
- Single (Outcomes Assessor)
Eligibility Criteria
- Ages
- 18 Years to — (Adult, Older Adult)
- Sex
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- •Adults scheduled for elective mitral (M-TEER) or tricuspid (T-TEER) transcatheter edge-to-edge repair procedures.
Exclusion Criteria
- •Insufficient proficiency in Dutch.
- •Severe visual or auditory impairment that would prevent full engagement with the VR content.
- •Any mental or physical condition that, in the judgment of the clinical team, significantly interferes with participation (e.g., advanced cognitive decline, acute psychological distress, or inability to tolerate wearing a VR headset).
Outcomes
Primary Outcomes
Change in Pre-procedural anxiety
Time Frame: 1 week prior to procedure
Change in state anxiety (S-STAI score) immediately after patient education (VR intervention vs. standard verbal education) and onw week prior to the procedure.
Secondary Outcomes
No secondary outcomes reported
Investigators
Abby Geerlings
PhD/MD
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)